Department of Hospital Pathology, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Department of Pathology and Thyroid Disease Center, Izumi City General Hospital, Izumi, Japan.
Cytopathology. 2024 May;35(3):383-389. doi: 10.1111/cyt.13360. Epub 2024 Jan 19.
Thyroid fine-needle aspiration (FNA) is a principal diagnostic procedure for thyroid nodules. A specific cytomorphological structure, known as the thyroid spherule, is often seen in FNA specimens. The clinical significance of these spherules in terms of diagnosis and prevalence remains largely unexplored.
We performed a retrospective study on 310 thyroid FNA specimens and categorized them according to the Bethesda System for Reporting Thyroid Cytopathology. The presence, size and number of thyroid spherules in each specimen were examined and these data were subsequently correlated with the clinicopathological features.
Thyroid spherules were almost exclusively detected in benign cases, comprising 7.6% of all benign diagnoses. The average diameter of spherules in benign cases was 84.9 μm. Benign cases and cases with atypia of undetermined significance cases primarily exhibited low cellularity, while follicular neoplasms and malignant cases typically showed moderate to high cellularity. In the subgroup of FNA cases with moderate to high cellularity, spherules were identified in 12 (20%) of 59 benign FNA cases. Within this group, the sensitivity and specificity of thyroid spherules for detecting benign FNA cases were 20% and 100%, respectively.
Our results suggest that the presence of thyroid spherules in FNA specimens can serve as a highly specific marker for benign thyroid conditions. The prevalence of spherule detection is strongly influenced by the cellularity. In cases with moderate to high cellularity, the identification of spherules can assist the cytopathologists in diagnosing thyroid FNA cases as benign.
甲状腺细针抽吸(FNA)是甲状腺结节的主要诊断程序。在 FNA 标本中经常可以看到一种称为甲状腺球体的特定细胞形态结构。这些球体在诊断和流行方面的临床意义在很大程度上尚未得到探索。
我们对 310 例甲状腺 FNA 标本进行了回顾性研究,并根据甲状腺细胞病理学报告的 Bethesda 系统对其进行了分类。检查了每个标本中甲状腺球体的存在,大小和数量,随后将这些数据与临床病理特征相关联。
甲状腺球体几乎仅在良性病例中检测到,占所有良性诊断的 7.6%。良性病例中球体的平均直径为 84.9μm。良性病例和意义不明的不典型病例主要表现为低细胞性,而滤泡性肿瘤和恶性病例通常表现为中至高细胞性。在中至高细胞性的 FNA 病例亚组中,在 59 例良性 FNA 病例中有 12 例(20%)发现了球体。在该组中,甲状腺球体检测良性 FNA 病例的敏感性和特异性分别为 20%和 100%。
我们的结果表明,FNA 标本中存在甲状腺球体可以作为良性甲状腺疾病的高度特异性标志物。球体检测的患病率受细胞性的强烈影响。在中至高细胞性的情况下,识别球体可以帮助细胞病理学家将甲状腺 FNA 病例诊断为良性。